Concerns Emerge Over FDA’s New Route for CRISPR Therapies
The Future of Personalized Gene Editing: What Lies Ahead When Baby KJ made headlines last year as the first recipient of a personalized gene-editing treatment, it sparked a big question: How can we help more children like KJ? In November, just six months after KJ’s groundbreaking journey began, two prominent figures from the Food and …









